MGB Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$887K Hold
825
0.25% 84
2025
Q3
$625K Sell
825
-1,055
-56% -$785K 0.18% 110
2025
Q2
$1.47M Sell
1,880
-188
-9% -$146K 0.48% 47
2025
Q1
$1.71M Buy
2,068
+121
+6% +$101K 0.62% 36
2024
Q4
$1.5M Buy
1,947
+805
+70% +$667K 0.47% 44
2024
Q3
$1.01M Buy
1,142
+115
+11% +$103K 0.37% 68
2024
Q2
$971K Hold
1,027
0.36% 72
2024
Q1
$799K Buy
1,027
+10
+1% +$7.12K 0.32% 75
2023
Q4
$592K Buy
+1,017
New +$594K 0.3% 91

Other funds holding LLY

MGB Wealth Management's LLY Position: Q4 2025 in Review

MGB Wealth Management held its Eli Lilly (LLY) position steady in Q4 2025 at 825 shares worth $887K. The position accounts for 0.25% of the portfolio, ranked #84.

MGB Wealth Management first reported a position in LLY in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.71M in Q1 2025. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • MGB Wealth Management held 825 shares of Eli Lilly worth $887K as of Q4 2025.
  • MGB Wealth Management left its Eli Lilly share count unchanged in Q4 2025.
  • Eli Lilly made up 0.25% of MGB Wealth Management's portfolio in Q4 2025, its #84 holding.
  • MGB Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 9 quarters since.
  • MGB Wealth Management's Eli Lilly position peaked at $1.71M in Q1 2025.
  • 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on MGB Wealth Management's 13F filing for Q4 2025, filed 17 Feb 2026.